Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Notes
Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice
Congyun JinYoshihiro MatsuiAtsushi Yonezawa Satoshi ImaiTakashi OgiharaKotaro ItoharaShunsaku NakagawaTakayuki NakagawaKazuo Matsubara
著者情報
ジャーナル フリー HTML

2021 年 44 巻 2 号 p. 283-286

詳細
抄録

Riboflavin (vitamin B2) plays an important role in cellular growth and function. Riboflavin transporter 2 (RFVT2) is widely expressed in several tissues, especially in the brain and salivary glands, and plays an important role in the tissue disruption of riboflavin. During the last 10 years, mutations in SLC52A2 have been documented in patients with a rare neurological disorder known as Brown–Vialetto–Van Laere syndrome. However, no suitable animal model of this disease has been reported. Here, we aimed to clarify the physiological role of RFVT2 using Slc52a2-mutant mice. The appearance, body weight, and plasma riboflavin concentration of Slc52a2 heterozygous mutant (Slc52a2+/−) mice were similar to those of wild-type (WT) mice. However, intercrossing between Slc52a2+/− mice failed to generate Slc52a2 homozygous mutant (Slc52a2−/−) mice. This suggested that Slc52a2 gene deficiency results in early embryonic lethality. Our findings suggested that RFVT2 is essential for growth and development, and its deletion may influence embryonic survival.

Fullsize Image
著者関連情報
© 2021 The Pharmaceutical Society of Japan
前の記事 次の記事
feedback
Top